reference/26876815

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/26876815

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase I\|Journal Article\|Multicenter Study\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	3814
issn	0732-183X 1527-7755
issueIdentifier	23
pageRange	3808-3814
publicationName	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
startingPage	3808
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_15a356c1d7d9ec8c7a8390cb91169325 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_0ba7ee80b57e34412c166eec3934db74 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_6bf53b9bcbb9cd7b08333b016935ee12 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_eaaaf9abb88ad8c36ec020f6a5cc76eb
bibliographicCitation	Shanafelt TD, Call TG, Zent CS, LaPlant B, Bowen DA, Roos M, Secreto CR, Ghosh AK, Kabat BF, Lee MJ, Yang CS, Jelinek DF, Erlichman C, Kay NE. Phase I trial of daily oral Polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia. J Clin Oncol. 2009 Aug 10;27(23):3808–14. PMID: 19470922; PMCID: PMC2727287.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f5c3e05f64179004e26d4e9fa4c72a58 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e2e14ad1a27c57de025e40bba78e2160 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e0bbb9c733ca39d67eb2fd5539e700b2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f80954239a2ee329970fced774efadea http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_69a77355daad3906e403eb21c0dfbe11 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_61c8cabd811a3490438efd50ac990f1a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0777c55ac743629cf33edfc3f9ddaa41 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b9ab956db25f245168340000ecebd603 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_63f8e82bec084520a5f2ca2a2c99d2b0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0c96ece3f4deceabce8f729c7605cfb7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1950aaf76b1361ab2f4149a45c69273b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2892e826b05943d26db66f9ce9fe3c64 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bed7ee6816c2802c7bc0dad1e45a7ada http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_40220a7536c6efa1152576754d1d8ec4
date	2009-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/19470922 https://doi.org/10.1200/jco.2008.21.1284 https://pubmed.ncbi.nlm.nih.gov/PMC2727287
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5023 https://portal.issn.org/resource/ISSN/0732-183X https://portal.issn.org/resource/ISSN/1527-7755
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Phase I Trial of Daily Oral Polyphenon E in Patients With Asymptomatic Rai Stage 0 to II Chronic Lymphocytic Leukemia
discusses	http://id.nlm.nih.gov/mesh/M0132653 http://id.nlm.nih.gov/mesh/M0021081 http://id.nlm.nih.gov/mesh/M0025302 http://id.nlm.nih.gov/mesh/M0003638 http://id.nlm.nih.gov/mesh/M0446957
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D002392Q000031 http://id.nlm.nih.gov/mesh/D016588Q000627 http://id.nlm.nih.gov/mesh/D015451Q000188 http://id.nlm.nih.gov/mesh/D015451Q000473
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D016588Q000008 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D009367 http://id.nlm.nih.gov/mesh/D002392Q000008 http://id.nlm.nih.gov/mesh/D018579 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D002392Q000097 http://id.nlm.nih.gov/mesh/D002392Q000627 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D013662 http://id.nlm.nih.gov/mesh/D002392Q000009 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D016588Q000009 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D000284 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D016588Q000097
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9720 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6590 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9772 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65064 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8593

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129601215 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128909635

Total number of triples: 74.